Gary G. Chicchi

4.7k total citations
65 papers, 2.5k citations indexed

About

Gary G. Chicchi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gary G. Chicchi has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 32 papers in Cellular and Molecular Neuroscience and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gary G. Chicchi's work include Neuropeptides and Animal Physiology (32 papers), Receptor Mechanisms and Signaling (30 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Gary G. Chicchi is often cited by papers focused on Neuropeptides and Animal Physiology (32 papers), Receptor Mechanisms and Signaling (30 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Gary G. Chicchi collaborates with scholars based in United States, United Kingdom and Austria. Gary G. Chicchi's co-authors include Margaret A. Cascieri, Marvin Bayne, Joy Applebaum, Nancy S. Hayes, Marc M. Kurtz, Barbara G. Green, Sharon Sadowski, Christopher J. Swain, Kwei‐Lan Tsao and Angela Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation Research.

In The Last Decade

Gary G. Chicchi

65 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary G. Chicchi United States	29	1.5k	862	784	473	374	65	2.5k
Michael L. McCaleb United States	31	1.1k 0.7×	276 0.3×	821 1.0×	491 1.0×	283 0.8×	72	2.9k
Chahrzad Montrose‐Rafizadeh United States	28	1.3k 0.9×	872 1.0×	648 0.8×	131 0.3×	779 2.1×	53	2.5k
Michael J. Coghlan United States	27	1.1k 0.7×	306 0.4×	361 0.5×	735 1.6×	93 0.2×	57	2.3k
Robert Ardecky United States	22	1.3k 0.8×	479 0.6×	343 0.4×	315 0.7×	85 0.2×	41	2.0k
Claus T. Christoffersen Denmark	20	884 0.6×	367 0.4×	175 0.2×	230 0.5×	143 0.4×	47	1.8k
Aaron S. Goetz United States	18	1.1k 0.7×	320 0.4×	398 0.5×	127 0.3×	335 0.9×	26	1.8k
J. Núñez France	28	1.2k 0.8×	580 0.7×	364 0.5×	130 0.3×	112 0.3×	83	2.4k
Xiao Yu China	31	1.9k 1.2×	199 0.2×	544 0.7×	99 0.2×	353 0.9×	107	2.8k
Nigel P. Shankley United States	26	1.6k 1.1×	136 0.2×	832 1.1×	184 0.4×	343 0.9×	84	2.9k
Fai Siu United States	15	1.9k 1.2×	179 0.2×	740 0.9×	169 0.4×	160 0.4×	16	2.2k

Countries citing papers authored by Gary G. Chicchi

Since Specialization

Citations

This map shows the geographic impact of Gary G. Chicchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary G. Chicchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary G. Chicchi more than expected).

Fields of papers citing papers by Gary G. Chicchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary G. Chicchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary G. Chicchi. The network helps show where Gary G. Chicchi may publish in the future.

Co-authorship network of co-authors of Gary G. Chicchi

This figure shows the co-authorship network connecting the top 25 collaborators of Gary G. Chicchi. A scholar is included among the top collaborators of Gary G. Chicchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary G. Chicchi. Gary G. Chicchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Zhong, Shuwen He, Edward C. Sherer, et al.. (2015). Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists. Bioorganic & Medicinal Chemistry Letters. 25(17). 3520–3525. 2 indexed citations

Kosinski, Jennifer, James Hubert, Paul E. Carrington, et al.. (2012). The Glucagon Receptor Is Involved in Mediating the Body Weight‐Lowering Effects of Oxyntomodulin. Obesity. 20(8). 1566–1571. 90 indexed citations

Day, Jonathan W., Vasily M. Gelfanov, David L. Smiley, et al.. (2012). Optimization of co‐agonism at GLP‐1 and glucagon receptors to safely maximize weight reduction in DIO‐rodents. Biopolymers. 98(5). 443–450. 111 indexed citations

Szewczyk, Jason W., John J. Acton, Alan D. Adams, et al.. (2010). Design of potent and selective GPR119 agonists for type II diabetes. Bioorganic & Medicinal Chemistry Letters. 21(9). 2665–2669. 21 indexed citations

Morriello, Gregori J., Sander G. Mills, Mikhail Reibarkh, et al.. (2010). Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(6). 2007–2012. 8 indexed citations

Singewald, Nicolas, Gary G. Chicchi, Kwei‐Lan Tsao, et al.. (2008). Modulation of basal and stress‐induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L‐822429. Journal of Neurochemistry. 106(6). 2476–2488. 45 indexed citations

Lin, Peter, Robert J. DeVita, Jonathan R. Young, et al.. (2007). The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine. Bioorganic & Medicinal Chemistry Letters. 17(18). 5191–5198. 11 indexed citations

Morriello, Gregori J., Robert J. DeVita, Sander G. Mills, et al.. (2007). Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists. Bioorganic & Medicinal Chemistry. 16(5). 2156–2170. 24 indexed citations

Elliott, Jason, Emma Carlson, Gary G. Chicchi, et al.. (2006). NK1 antagonists based on seven membered lactam scaffolds. Bioorganic & Medicinal Chemistry Letters. 16(11). 2929–2932. 15 indexed citations

10.

Huscroft, Ian T., Emma Carlson, Gary G. Chicchi, et al.. (2006). 1-Phenyl-8-azabicyclo[3.2.1]octane ethers: A novel series of neurokinin (NK1) antagonists. Bioorganic & Medicinal Chemistry Letters. 16(7). 2008–2012. 18 indexed citations

11.

Elliott, Jason, Robert W. Carling, Gary G. Chicchi, et al.. (2006). N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters. 16(22). 5752–5756. 15 indexed citations

12.

Carlson, Emma, José L. Castro, Gary G. Chicchi, et al.. (2002). 4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters. 12(13). 1759–1762. 16 indexed citations

13.

Maubach, Karen, Karine Martin, Gary G. Chicchi, et al.. (2002). Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus. Neuroscience. 109(3). 609–617. 60 indexed citations

14.

Shaw, Duncan, Gary G. Chicchi, Jason Elliott, et al.. (2001). 2-Aryl indole NK1 antagonists: optimisation of the amide substituent. Bioorganic & Medicinal Chemistry Letters. 11(23). 3031–3034. 10 indexed citations

15.

Elliott, Jason, Margaret A. Cascieri, Gary G. Chicchi, et al.. (1998). Serine derived NK1 antagonists 1: The effect of modifications to the serine substituents. Bioorganic & Medicinal Chemistry Letters. 8(14). 1845–1850. 7 indexed citations

16.

Chicchi, Gary G., Michael P. Graziano, Patricia J. Hey, et al.. (1997). Alterations in Receptor Activation and Divalent Cation Activation of Agonist Binding by Deletion of Intracellular Domains of the Glucagon Receptor. Journal of Biological Chemistry. 272(12). 7765–7769. 25 indexed citations

17.

Graziano, M P, et al.. (1993). Cloning and Functional Expression of a Human Glucagon-like Peptide-1 Receptor. Biochemical and Biophysical Research Communications. 196(1). 141–146. 49 indexed citations

18.

Cascieri, Margaret A., Gary G. Chicchi, & Marvin Bayne. (1991). Characterization of the Biological Activity of IGF I Analogs with Reduced Affinity for IGF Receptors and Binding Proteins. Advances in experimental medicine and biology. 293. 23–30. 6 indexed citations

19.

Cascieri, Margaret A., Richard Saperstein, Nancy S. Hayes, et al.. (1988). Serum Half-Life and Biological Activity of Mutants of Human Insulin-Like Growth Factor I which Do Not Bind to Serum Binding Proteins. Endocrinology. 123(1). 373–381. 56 indexed citations

20.

Cascieri, Margaret A., Nancy S. Hayes, Bruce Kelder, et al.. (1988). Inability of a Mouse Cell Line Transformed to Produce Biologically Active Recombinant Human Insulin-Like Growth Factor I (IGF-I) to Respond to Exogenously Added IGF-I. Endocrinology. 122(4). 1314–1320. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact